Skip to main
CTRE
CTRE logo

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

CareTrust REIT's planned $817 million merger with Care REIT is anticipated to bring immediate accretion, enhancing the company’s financial performance and growth potential. The merger positions CareTrust to effectively utilize its under-leveraged balance sheet, which could further support expansion and investment opportunities in the healthcare real estate sector. This strategic move into the UK market reflects a robust growth strategy that may bolster CareTrust's revenue streams and operational efficiency.

Bears say

The financial outlook for CareTrust REIT is tempered by significant risks related to tenant stability and potential disruptions, which could hinder earnings growth and impact financial performance. Additionally, the company's initial lease yield of 8.1% is notably lower than the approximately 10% cash lease yields reported by comparable U.S. REIT peers, raising concerns about its competitive positioning in the market. Furthermore, the issue of tax leakage, with potential impacts of 50 to 100 basis points on investment yield due to the repatriation of profits, further compounds the challenges facing the company's financial outlook.

CareTrust REIT (CTRE) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 7 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Nov 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.